BioNexus Gene Lab Corp. (BGLC)
undefined
undefined%
At close: undefined
0.35
-5.41%
After-hours Jan 06, 2025, 07:56 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Net Income -2.63M -355.97K 751.57K 1.09M -246.47K 26.45K -123.75K -835
Depreciation & Amortization 108.42K 105.42K 108.22K 101.60K 53.33K 40.61K 15.03K n/a
Stock-Based Compensation 511.74K n/a n/a n/a n/a n/a n/a n/a
Other Working Capital -23.12K -129.67K 39.98K 68.49K -11.01K -357.93K n/a n/a
Other Non-Cash Items 589.31K -38.81K 11.62K -745.38K 129.55K 528.04K -382.62K n/a
Deferred Income Tax n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital 117.98K 833.38K -862.25K 102.36K -24.14K -341.14K 439.31K n/a
Operating Cash Flow -1.30M 544.03K 9.16K 552.68K -217.27K -274.08K 357.22K -835
Capital Expenditures -149.40K -54.17K -3.16K -421.62K -12.82K -39.62K -314.82K n/a
Acquisitions n/a n/a n/a 346.01K n/a n/a -5.00M n/a
Purchase of Investments -320.73K -511.71K -515.84K -108.63K n/a -12.08K n/a n/a
Sales Maturities Of Investments 26.15K n/a 6.39K 30.06K n/a n/a n/a n/a
Other Investing Acitivies 61.41K 115.38K 22.04K 1.47M -12.82K -12.08K n/a n/a
Investing Cash Flow -382.58K -450.50K -490.57K 1.32M -12.82K -51.70K -5.31M n/a
Debt Repayment n/a -34.04K -26.30K -4.95K -16.78K n/a n/a n/a
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a -115.38K -22.04K -6.31K n/a n/a n/a n/a
Other Financial Acitivies 5.75M n/a -1.92K n/a -164.03K 742.94K 5.78M 638.00
Financial Cash Flow 5.75M 115.96K -28.22K -4.95K -180.81K 742.94K 5.78M 638.00
Net Cash Flow 3.81M -5.05K -663.77K 1.93M -401.16K 421.09K 839.12K -108
Free Cash Flow -1.45M 489.86K 6.00K 131.06K -230.09K -313.70K 42.40K -835